INmune Bio, Inc. (INMB)
NASDAQ·Healthcare·Biotechnology
$1.41
-4.42%
Mkt Cap $39.08M
Next Earnings
In 8 daysWed, May 6, 2026
EPS Estimate
-$0.24
2 analysts
Revenue Estimate
$1.11M
Last quarter: beat by +33.33% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$39.08M
P/E
—
Fwd P/E
—
P/S
696.53
Rev TTM
—
EPS TTM
-$1.92